Clinical Trial Update: Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite [Phase 1]

View source ↗

Summary

This is a Phase 1 safety study evaluating the Leish-111f + MPL-SE vaccine for prevention of cutaneous leishmaniasis in healthy adults previously exposed to Leis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Leish-111f + MPL-SE vaccine (Leish-111f with MPL-SE adjuvant)

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Cutaneous Leishmaniasis | Phase 1 | Status: COMPLETED